Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

PAIN MANAGEMENT - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Pain Management in US$ Million by the following product segments: Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 116 companies including many key and niche players such as AstraZeneca PLC, Eli Lilly and Company, Glaxo Smithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer, Inc., Wyeth, Purdue Pharma, and Sanofi Aventis. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-1130
Price : $4500
Companies : 116
Pages : 660
Date : January 2011
Market Data Tables : 60

Complimentary Copy of Study Findings:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  PAIN MANAGEMENT (Complete Report) Pages : 660   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS......14 $295  
   Study Reliability and Reporting Limitations......1  
   Disclaimers......2  
   Data Interpretation & Reporting Level......3
Quantitative Techniques & Analytics......3
Product Definition and Scope of Study......3
Pain Management Pharmaceuticals......3
  
   Pain Management Devices......4
Pain Management Services......4
  
  2. INDUSTRY OVERVIEW.......57 $595  
   Pain Management Market to Witness Steady Growth.......5
Current And Future Analysis.......5
Market Analysis By Segment.......5
1$100
   Factors Affecting Pain Management Industry.......6
Challenges Faced.......6
Trends and Issues.......6
Future Prospects Bright for Pain Relieving Drug Market.......6
1$100
   Generic Drugs Hog the Limelight.......7
Cox II Crisis Tarnishes Industry Growth.......7
Novel Therapies to Propel Opioid and Non- Opioid Therapies.......7
1$100
   Neuropathic Pain - Still an Underserved Market.......81$100
   Cyclin-dependent kinase 5 (Cdk5).......9
Drug Dynamics in the Migraine Market.......9
Pain Pathways – Gain a Second Look.......9
1$100
   Leading Players.......10
Generics to Inundate Pain Management Drug Market Further.......10
Table 1: Leading Players in the Global Pain Management Pharmaceuticals Market (2009): Market Share Breakdown of Value Sales for Pfizer, Eli Lilly, Johnson & Johnson, Endo Pharma, Novartis and Others (includes corresponding Graph/Chart).......10
1$350
   Status of Major Pipeline Drugs for Pain Management.......11
1$100
  3. PRODUCT OVERVIEW.......1223 $1450  
   Pain Management: An Overview.......12
Managing Pain.......12
What is Pain?.......12
1$100
   Assessment of Pain.......13
Pain Management.......13
1$100
   Pain Management for Neonates.......14
Pain Management in Kids.......14
Pain Management in Older Adult Surgical Patients.......14
1$100
   Pain Therapeutics – An Introduction.......151$100
   Treatment of Pain.......16
Pharmacologic Method.......16
1$100
   Non-pharmacological Method.......17
Invasive Procedures.......17
1$100
   Palliative Care.......18
Alternative Methods.......18
Acupuncture.......18
1$100
   Biofeedback.......19
Bioelectromagnetic Therapy.......19
Biomagnetism and Magnetotherapy.......19
Guided Imagery.......19
Manual/Massage Therapies.......19
Aromatherapy Massage.......19
1$100
   Swedish Massage.......20
Deep Tissue Massage.......20
Neuromuscular Therapy.......20
Myofascial Release.......20
Manual Lymph Drainage.......20
Cranial Sacral Therapy.......20
1$100
   Reflexology.......21
Naturopathy.......21
1$100
   Relaxation Therapy.......22
Transcendental Meditation.......22
Classification of Pain.......22
Acute Pain.......22
Postoperative pain.......22
1$100
   Labor pain.......23
Visceral pain.......23
Migraine.......23
Treatment of Migraine.......23
1$100
   Chronic Pain.......24
Cancer pain.......24
Back Pain.......24
1$100
   Neuropathic Pain.......25
Arthritic Pain.......25
HIV-Related Pain.......25
1$100
   Diabetic Neuropathy.......261$100
   Osteo-and Rheumatoid Arthritis Pain.......27
Pain Management Products and Services.......27
Pain Management Pharmaceuticals.......27
Over-the-counter Drugs.......27
Acetaminophen.......27
Aspirin.......27
Ibuprofen.......27
1$100
   Ketoprofen.......28
Naproxen.......28
Pramoxine.......28
Counterirritants.......28
Triethanolamine Salicylate (Trolamine).......28
1$100
   Prescription Drugs.......29
General Anesthetics.......29
Local Anesthetics.......29
Non-steroidal Anti-Inflammatories (NSAIDs).......29
1$100
   Non-opioid Analgesics.......30
Opioid Analgesics.......30
2$200
   Pain Management Devices.......32
Electrical Spinal Cord Stimulators.......32
Electrical Stimulus Devices.......32
Transcutaneous Electric Nerve Stimulators (TENS).......32
1$100
   Patient-Controlled Analgesia Infusion Devices.......33
Pain Management Services.......33
Home Care/Providence Home Health.......33
Providence Hospices.......33
Pain Management Centers and Clinics.......33
1$100
   Pain Rehabilitation Programs.......34
1$100
  4. REGULATORY ENVIRONMENT.......35   
   OTC Painkillers to Carry Conspicuous Safety Warnings.......35
Federal Regulatory Norms of Controlled Substances.......35
DEA Regulations.......35
2$200
  5. PRODUCT INNOVATIONS/INTRODUCTIONS.......378 $595  
   Venus Remedies to Unveil Aceclofenac OD.......37
Sandoz International Launches Metaxalone Tablets in US.......37
Covidien Unveils EXALGO™ Extended-Release Tablets.......37
1$100
   Bresslergroup Develops Dental Vibe for Pain-Free Dental Injections.......38
Competitive Technologies Launches Calmare® Medical Device.......38
Victory Pharma Unveils Naprelan Dose Card.......38
1$100
   BIOLASE Technology Launches Diolase 10™ Diode Laser.......39
Dr. Reddy's Laboratories Unveils Finrid Transdermal Patch.......39
Cumberland Pharmaceuticals Unveils Caldolor® in US.......39
1$100
   Tenscare Launches Iglove.......40
Piramal Launches BioElectronics' ActiPatch in India.......40
Victory Pharma to Introduce Supplementary NAPRELAN Products.......40
1$100
   Lannett Unveils Two New Products.......41
Glenmark Rolls Out Morphine Oral Solution in the US.......41
Acrux Introduces New NSAID Formulations.......41
Amrutanjan Healthcare Relaunches Amrutanjan Pain Balm.......41
ConvaTec Introduces SUR-FIT Natura® Low-Pressure Adaptor.......41
1$100
   Cosman Medical Launches G4 Four-Output RF Generator.......42
Origin BioMed Unveils Neuragen.......42
Biotanika Health Rolls Out Natural Product Range.......42
B. Braun Medical Introduces Curlin 6000 CMS.......42
1$100
   Dynatronics Launches DynaPro Spinal Health System.......43
ProEthic Pharmaceuticals Unveils Ibudone.......43
Endo Pharmaceuticals to Introduce New Dosage Strengths of OPANA®ER.......43
Dr. Reddy's Laboratories Unveils Supanac.......43
Troikaa Pharmaceuticals Rolls Out DYNAPAR AQ 1ml.......43
1$100
   Janssen-Cilag International to Launch IONSYS™.......44
1$100
  6. PRODUCT INNOVATIONS/INTRODUCTIONS IN THE RECENT PAST – A PERSPECTIVE
  BUILDER.......45
3 $295  
   Mallinckrodt Introduces Novel Pain Relieving Agent.......45
Shionogi Unveils Cancer Pain Management Drug.......45
NeuroTherm Launches RF Generators for Treatment of Heel Pain.......45
McNeil Brings Chewable TYLENOL® GoTabs Tablets.......45
1$100
   Barr Unveils Generic Version of ACTIQ®.......46
Orthofix Unveils e-PainCare.......46
Organon Innovates Org 25969.......46
Orthofix’s BREG Division Launches Polar Care Motorized Cold Therapy System.......46
Zynex Develops New Pain Management Device.......46
1$100
   Eli Lilly and Company Develops Cymbalta.......47
Pfizer’s Lyrica Gets Nod from the EC.......47
New Pain Management Infusion Pumps from Sorenson.......47
McKinley Unveils Accufuser Pain Management System.......47
1$100
  7. RECENT INDUSTRY ACTIVITY.......4824 $1450  
   Grünenthal’s Tapentadol Clears European Decentralised Procedure.......48
Stryker to Acquire Pain-Management Device Unit of Boston Scientific.......48
Axxess Pharma to Ink License Agreement for a New Prescription Drug.......48
1$100
   Endo Pharmaceuticals Acquires HealthTronics.......49
Purdue Pharma Secures FDA Approval for Transdermal System.......49
Discus Acquisition Takes Over Outstanding Shares of Javelin Pharmaceuticals.......49
Cannabis Science to Acquire Montana Pain Management.......49
1$100
   Roxro Pharma Receives FDA Approval for SPRIX™ Nasal Spray.......50
Ralfinamide Fails to Show Benefits in Phase IIb Trial.......50
NeuroTherm Acquires Smith & Nephew's Interventional Spine Pain Management
  Assets.......50
1$100
   Horizon Therapeutics Merges with Nitec Pharma.......51
Gentiva Takes Over Heart to Heart Hospice.......51
Millennium Laboratories Inks National Agreement with Aetna.......51
1$100
   PatientsLikeMe Takes Over ReliefInsite.com.......52
TeamHealth Hospital Staffing Firm Acquires Anesthetix Management.......52
CombinatoRx Merges with Neuromed Pharmaceuticals.......52
1$100
   Roche Licenses P2X31 Receptor Program to Afferent Pharmaceuticals.......53
Lannett Obtains FDA approval for Producing Hydromorphone Hydrochloride Tablets.......53
Anesiva Inks an Asset Purchase Agreement with PowderJect Technologies.......53
Millennium Laboratories Inks Agreement with Three Rivers Provider Network.......53
1$100
   Cumberland Pharmaceuticals Partners with Phebra to Promote Caldolor®.......54
Sciele Pharma Acquires Addrenex Pharmaceuticals.......54
Bioniche Pharma Acquires Injectable Drugs from Xanodyne.......54
1$100
   NeurogesX Obtains FDA Approval for Qutenza™.......55
Cerimon Acquires Development and Commercialization Rights for Diclofenac in
  Europe.......55
Hydra Biosciences Collaborates with Cubist.......55
1$100
   Zambon Spa Inks a Licensing Agreement with Indena Spa.......56
Pfizer Acquires Wyeth.......56
B. Braun Bags Contract from HealthTrust Purchasing Group.......56
1$100
   QRxPharma Enters into Partnership with Patheon to Produce Clinical Supplies.......57
Kimberly-Clark to Acquire I-Flow.......57
1$100
   Kimberly-Clark Takes Over Pain Management Business of Baylis Medical.......58
WraSer Pharmaceuticals Purchases Trezix® from e5 Pharma.......58
TorreyPines Therapeutics Merges with Raptor Therapeutics.......58
1$100
   GSK Enters into Agreement with Dr Reddy's Laboratories.......59
Patterson Medical Acquires DJO’s Supply Catalog and Rehabilitation Equipment
  Business.......59
Mallinckrodt Acquires Licensing Rights from Neuromed.......59
Nuvo Research Enters into Licensing Agreement with Mallinckrodt.......59
1$100
   Bederra Plans to Take Over Neogenex.......60
Z-Cube Inks Deal with Yissum.......60
XenaCare Acquires US License for Homeopathic Treatment.......60
Symbios Ropes in Distributors to Market Pain Management Products Across US.......60
Teikoku Pharma Takes Over Travanti Pharma.......60
1$100
   Diamyd Licenses Endomorphin Technology.......61
Competitive Technologies and Life Episteme Enters into an Agreement.......61
Bederra Enters into Collaboration with Pain Management Center.......61
1$100
   Javelin Pharmaceuticals Signs Agreement with Therabel Pharma.......62
Biotanika Inks Deal with Xymogen.......62
HSR Clears Solvay Pharmaceuticals and Depomed's Licensing Agreement.......62
BioDelivery Sciences and Meda Ink an Agreement.......62
Endo Pharmaceuticals to Take Over Indevus Pharmaceuticals.......62
Actavis US Acquires Kadian.......62
1$100
   Labopharm Receives Approval from U.S. Food and Drug Administration.......63
Albert Acquisition Acquires Alpharma.......63
Sosei Group Re-acquires Commercialization Rights for AD 923.......63
Sun Pharmaceutical Industries Purchases Chattem Chemicals.......63
Piramal Healthcare Inks Agreement with Minrad International.......63
1$100
   AgION Technologies and Stryker’s Instruments Division Enter into Agreement.......64
Elder Pharmaceuticals and Global Energy Medicines Sign Agreement.......64
Wound Management Technologies to Take Over BioPharma Management Technologies.......64
NovaMed Purchases Stake in The Center for Specialized Surgery.......64
1$100
   RxElite Ends Agreement with Minrad International.......65
Johnson & Johnson Receives FDA Approval for Tapentadol.......65
Mundipharma International and Purdue Pharma Ink Alliance with Infinity.......65
Zynex Obtains CE Mark for IF8100 and IF8000 Pain-Managing Devices.......65
Competitive Technologies and Able Global Healthcare Ink an Agreement.......65
1$100
   National Surgical Hospitals Inks New Joint Venture.......66
Getting Ready and Winston Laboratories Merge.......66
Competitive Technologies and Biogene Pharma Ink an Agreement.......66
MEKT and ProtoKinetix Enter into Agreement.......66
Tronics Microsystems Takes Over MedTech Development.......66
1$100
   NSC Purchases Ardmore Regional Surgery Center and Kenwood Surgery Center.......67
Mallinckrodt and Purdue Pharma Sign Agreement.......67
Javelin Pharmaceuticals and Baxter Healthcare Enter into Agreement.......67
Competitive Technologies and Excel Life Sciences Ink an Agreement.......67
1$100
   Theragenics to Buy NeedleTech Products.......68
Wyeth Consumer Healthcare Inks Agreement with Procter & Gamble.......68
NovaMed Purchases Majority Stake in Interventional Pain Management Center.......68
Option Care Enterprises Takes Over CuraScript Infusion Pharmacy.......68
1$100
   Eli Lilly Obtains FDA Approval for Cymbalta®.......69
Curlin Medical Receives Contract from Premier.......69
EUSA Pharma Acquires Cytogen.......69
American Oriental Enters into Alliance with China Aoxing Pharmaceutical.......69
1$100
   Treximet Bags Approval from FDA.......70
LMA International Takes Over Breg's Pain Management Operations.......70
Hospira and HealthTrust Purchasing Group Enter into Agreement.......70
Hebei Aoxing Pharmaceutical Purchases Shijiazhuang Lerentang Pharmaceutical.......70
1$100
   Bederra Signs Letter of Intent with Lumar Diagnostic Imaging.......71
Integrated Pain Solutions and Devon Health Services Sign Agreement.......71
Maneesh Pharmaceuticals Purchases Smyle.......71
1$100
  8. CORPORATE ACTIVITY IN THE RECENT PAST – A PERSPECTIVE BUILDER.......7212 $950  
   Eli Lilly and Glenmark Pharmaceuticals Ink an Agreement.......72
Orexo Takes Over Biolipox.......72
ReAble Therapeutics to Acquire Shares of IOMED.......72
Integra LifeSciences Buys Assets of Pain Management Operations of Physician
  Industries.......72
1$100
   CeNeS Obtains IND Clearance for M6G from FDA.......73
Infinity Acquisition Takes Over Life Without Pain.......73
Neuromed to Acquire US Rights for Oros Hydromorphone from Alza.......73
1$100
   China Aoxing to Acquire Chinese Pharmaceutical Company, Shijiazhuang Le Ren.......74
Vyteris Holdings to Acquire Lehigh Valley Technologies.......74
1$100
   Younger America Pockets Life Without Pain.......75
PainCare Divests Center for Pain Management.......75
Grand Slam Acquires IOMED.......75
Ligand Accomplishes Divesture of AVINZA.......75
CeNeS and Ergomed Collaborate for Phase II Trials of NMDA Antagonist CNS 5161.......75
1$100
   Sorenson Secures Approval to Market Ambulatory Infusion Pump in China.......76
PainCare Pockets CPMASC.......76
Moog Takes Over Mckinley Medical Corp.......76
PainCare Acquires REC, CareFirst Medical Associates.......76
CLL Pharma Acquires Synt:em.......76
1$100
   AstraZeneca Partners with Pozen to Bring Novel Pain Management Therapy.......77
Great Outdoors Acquires Somatic Systems Institute.......77
PainCare Partners with Solstice Neurosciences to Offer Pain Management in CD.......77
Elan Confers Eisai with European Rights of Prialt.......77
Evotec Partners with Apeiron Biologics to Bring Novel Pain Therapy.......77
1$100
   Alpaca Enterprises Acquires Neuroscience Therapy Corp.......78
PainCare Holdings Acquires Desert Pain Medicine Group........78
Wex Pharma Inks Agreement With Boston Children’s Hospital.......78
Glenmark Inks Agreement with LVT to Market Pain Management Products.......78
EKR Attains North American Marketing Rights for Gelclair.......78
Grand Slam Acquires Cefar Medical.......78
1$100
   Omeros Acquires Nura.......79
Hospira Inks Agreement with Premier.......79
Pain Therapeutics Enters into Alliance with King Pharmaceuticals.......79
Corgentech Merges with AlgoRx.......79
Elder Pharmaceuticals Ventures into the Indian Pain Management Market.......79
1$100
   Xanodyne Acquires Pharmaceutical Assets of aaiPharma.......80
Pro-Dex Acquires Dental Technology From IntraVantage.......80
Encore Medical Acquires Compex Technologies.......80
Sosei Acquires Arakis.......80
Corgentech Signs Definitive Merger Agreement With AlgoRx.......80
1$100
   Elder Pharmaceuticals Enters into Marketing Agreement with TRB Chemedica.......81
University Pain Management Center Signs Agreement with Somnia.......81
Entelos and Organon to Extend Rheumatoid Arthritis (RA) Collaboration.......81
1$100
   NovaMed Establishes a New Pain Management Center at Indiana.......82
Organon and Uriach Collaborate on Developing Kinase Inhibitors.......82
Toray and Nippon To Co-Develop THCR.......82
AAIPharma Acquires Pain Products.......82
1$100
   PainCare & Spine & Pain Center in a Definitive Merger Agreement .......83
Elan and Ingenium in a Strategic Alliance.......83
1$100
  9. FOCUS ON SELECT KEY PLAYERS.......843 $295  
   AstraZeneca PLC (UK).......84
Eli Lilly and Company (USA).......84
GlaxoSmithkline Plc (UK).......84
Johnson & Johnson (USA).......84
1$100
   Merck & Co., Inc. (USA).......85
Novartis Pharmaceuticals Corp. (USA).......85
Pfizer, Inc. (USA).......85
Wyeth (USA).......85
1$100
   Purdue Pharma (USA).......86
Sanofi Aventis (France).......86
1$100
  10. GLOBAL MARKET PERSPECTIVE.......87   
   Table 2: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......871$350
   Table 3: World Historic Review for Pain Management by Geographic Region – US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......881$350
   Table 4: World 11-Year Perspective for Pain Management by Geographic Region – Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......891$350
   Table 5: World Recent Past, Current & Future Analysis for Pain Management Pharmaceuticals by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......901$350
   Table 6: World Historic Review for Pain Management Pharmaceuticals by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......911$350
   Table 7: World 11-Year Perspective for Pain Management Pharmaceuticals by Geographic Region – Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......921$350
   Table 8: World Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......931$350
   Table 9: World Historic Review for Pain Management Devices by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......941$350
   Table 10: World 11-Year Perspective for Pain Management Devices by Geographic Region – Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia- Pacific (ex2008cluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......951$350
   Table 11: World Recent Past, Current & Future Analysis for Pain Management Services by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......961$350
   Table 12: World Historic Review for Pain Management Services by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......971$350
   Table 13: World 11-Year Perspective for Pain Management Services by Geographic Region – Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......98
1$350
  11. THE UNITED STATES.......995 $950  
   A. Market Analysis.......99
Pain Statistics in the US.......99
Industry Overview.......99
1$100
   Current & Future Analysis.......100
Opioids Pain Management Market to Garner Sizeable Growth.......100
Safety Concerns Restrict Large Scale Adoption.......100
1$100
   Measures to Thwart Drug Abuse.......101
Market for Cancer Pain Therapeutics.......101
Leading Players/Brands – A Recent Past Scenario.......101
Table 14: Leading Oral Pain Relievers in the US Market for Pain Management (2006) – Percentage Breakdown of Value Sales by Brand for Orajel, Anbesol, Baby Orajel, Colgate Peroxyl, Zilactin, Glyoxide, Hyland's, Dentek Temparin, Orajel Mouth Aid, and Others (includes corresponding Graph/Chart).......101
1$350
   Table 15: Leading OTC Pain Relievers in the US Market for Pain Management (2006) – Percentage Breakdown of Value Sales by Brand for Advil, Tylenol, Aleve, Bayer, Tylenol PM, Motrin IB, Excedrin, Tylenol Arthritis, Excedrin Migraine, Private label, and Others (includes corresponding Graph/Chart).......102
B. Market Analytics.......102
Table 16: The US Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......102
1$350
   Table 17: The US Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......103

Table 18: The US 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 2005, 2010 & 2015 (Includes corresponding graphs/chart).......103
1$350
  12. CANADA.......1042 $595  
   Market Analysis.......104
Table 19: Canadian Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......104
1$350
   Table 20: Canadian Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......105

Table 21: Canadian 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).......105
1$350
  13. JAPAN.......1062 $595  
   A. Market Analysis.......106
Current & Future Analysis.......106
B. Market Analytics.......106
Table 22: Japanese Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......106
1$350
   Table 23: Japanese Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......107

Table 24: Japanese 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).......107
1$350
  14. EUROPE.......1086 $1450  
   A. Market Analysis.......108
Current & Future Analysis.......108
1$100
   B. Market Analytics.......109
Table 25: European Recent Past, Current & Future Analysis for Pain Management by Geographic Region – France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......109
1$350
   Table 26: European Historic Review for Pain Management by Geographic Region – France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1101$350
   Table 27: European 11-Year Perspective for Pain Management by Geographic Region – Percentage Breakdown of Dollar Revenue for France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1111$350
   Table 28: European Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1121$350
   Table 29: European Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices And Pain Management Services Markets Independently Analyzed With Annual Revenue Figures in US$ Million For Years 2000 through 2006 (includes corresponding Graph/Chart).......113

Table 30: European 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......113
1$350
  14a. FRANCE.......1142 $595  
   Market Analysis.......114
Table 31: French Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......114
1$350
   Table 32: French Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......115

Table 33: French 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......115
1$350
  14b. GERMANY.......1162 $595  
   Market Analysis.......116
Table 34: German Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......116
1$350
   Table 35: German Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......117

Table 36: German 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......117
1$350
  14c. UNITED KINGDOM.......1183 $595  
   A. Market Analysis.......118
Key Statistics Related to Pain Management in the UK.......118
1$100
   B. Market Analytics.......119
Table 37: UK Recent Past, Current & Future Analysis for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......119
1$350
   Table 38: UK Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......120

Table 39: UK 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......120
1$350
  14d. ITALY.......1212 $595  
   Market Analysis.......121
Table 40: Italian Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......121
1$350
   Table 41: Italian Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......122

Table 42: Italian 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......122
1$350
  14e. SPAIN.......1232 $595  
   Market Analysis.......123
Table 43: Spanish Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......123
1$350
   Table 44: Spanish Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......124

Table 45: Spanish 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......124
1$350
  14f. RUSSIA.......1252 $595  
   Market Analysis.......125
Table 46: Russian Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......125
1$350
   Table 47: Russian Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......126

Table 48: Russian 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......126
1$350
  14g. REST OF EUROPE.......1273 $950  
   Market Analysis.......127
Table 49: Rest of Europe Recent Past, Current & Future Analysis for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......127
1$350
   Table 50: Rest of Europe Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1281$350
   Table 51: Rest of Europe 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......129
1$350
  15. ASIA-PACIFIC.......1304 $950  
   A. Market Analysis.......130
Current & Future Analysis.......130
India.......130
1$100
   B. Market Analytics.......131
Table 52: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......131
1$350
   Table 53: Asia-Pacific Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1321$350
   Table 54: Asia-Pacific 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......133
1$350
  16. LATIN AMERICA.......1343 $950  
   Market Analysis.......134
Table 55: Latin American Recent Past, Current & Future Analysis for Pain Management by Product Segment –Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......134
1$350
   Table 56: Latin American Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1351$350
   Table 57: Latin American 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......136
1$350
  17. REST OF WORLD.......1372 $595  
   Market Analysis.......137
Table 58: Rest of World Recent Past, Current & Future Analysis for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2010 (includes corresponding Graph/Chart).......137
1$350
   Table 59: Rest of World Historic Review for Pain Management by Product Segment – Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......138

Table 60: Rest of World 11-Year Perspective for Pain Management by Product Segment – Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......138
1$350
COMPETITION 512$995
  
Total Companies Profiled: 116 (including Divisions/Subsidiaries - 130)

Region/Country                 Players


The United States                 80    
Canada                             4
Japan                              5
Europe                            32 
     France                        4
     Germany                       4
     The United Kingdom           11 
     Italy                         2
     Rest of Europe               11 
Asia-Pacific (Excluding Japan)     7
Latin America                      1
Middle-East                        1
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign